75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT EQUITY (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Nature of Business and Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Discontinued Operations
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - XOMA Transaction
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Collaboration Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Cash and Cash Equivalents
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Debt
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Liability Related to Sale of Royalties
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Reverse Stock Split
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Grant Agreement
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Net Loss per Share
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Equity
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Segment Information
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Nature of Business and Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Discontinued Operations (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Cash and Cash Equivalents (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Liability Related to Sale of Royalties (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Net Loss per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Equity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Segment Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Nature of Business and Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Discontinued Operations - Summary of Reconciliation of Carrying Amounts of Assets and Liabilities and Income (Loss) from Discontinued Operation (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Discontinued Operations - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - XOMA Transaction - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Collaboration Agreements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Fair Value Measurements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Cash and Cash Equivalents - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Cash and Cash Equivalents - Schedule of Cash and Cash Equivalents (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Debt - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Liability Related to Sale of Royalties - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Liability Related to Sale of Royalties - Schedule of Changes in the Liability Related to the Sale of Royalties (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Leases - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Leases - Components of Lease Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Leases - Summary of Right of Use Assets Acquired Under Operating Leases (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities - Summary of Prepaid Expenses and Other Current Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Reverse Stock Split - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Grant Agreement - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Net Loss per Share - Computation of Basic and Diluted Net Loss per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Net Loss per Share - Summary of Potentially Dilutive Shares Excluded from Calculation of Net Loss Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Equity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Equity - 2023 and 2024 Common Warrants - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Equity - 2024 Common Warrants - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Equity - 2025 Equity Offerings and Common Warrants - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Equity - Summary of Assumptions Used to Estimate the Fair Value of the Warrants Using The Black-scholes Option Pricing Model (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Equity - 2026 Niowave Common Warrants - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Equity - Standby Equity Purchase Agreement - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Equity - At The Market Offering Agreement - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Equity - Summary of Common Warrant Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Segment Information - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Segment Information - Summary of Significant Expense Categories (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Segment Information - Summary of Significant Asset Categories (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Subsequent Events - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Line Of Credit Facility [Line Items]
Line of Credit Facility [Line Items]
Related Party Transaction [Table]
Basis of Presentation
Basis of Presentation and Significant Accounting Policies [Text Block]
Scenario
Scenario [Axis]
Schedule of Accrued Liabilities [Table Text Block]
Summary of Accrued Expenses and Other Current Liabilities
Preferred stock, shares issued
Preferred Stock, Shares Issued
Debt
Debt Disclosure [Text Block]
Operating Lease, Liability, Total
Operating lease liability
Operating Lease, Liability
Existing Warrants
Existing Warrants [Member]
Existing warrants.
Income from discontinued operations
Income from discontinued operations
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Income from discontinued operations
Operating Lease, Right-of-Use Asset, Periodic Reduction
Non-cash lease expense
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted Average Number of Shares Outstanding, Diluted
Diluted shares used in calculation
Other Significant Accounting Policies
Other Significant Accounting Policy [Text Block]
Other significant accounting policy.
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total
Stock-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Minimum
Minimum [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total
Common stock issued upon vesting of restricted stock units (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Private Placement
Private Placement [Member]
Letter of Credit
Letter of Credit [Member]
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred stock, shares outstanding
Preferred Stock, Shares Outstanding
Deferred payments increase percentage
Deferred Payments Increase Percentage
Deferred payments increase percentage.
Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]
Summary of Fair Value of Common Warrants Prior to and Immediately After Exercise Price Adjustment, were Estimated Using Black-Scholes Option-Pricing Model Assumptions
Summary of Assumptions Used to Estimate the Fair Value of the Warrants Using The Black-scholes Option Pricing Model
2023 Common Warrants [Member]
2023 Common Warrants.
2023 Common Warrants
Credit Agreement
Credit Agreement [Member]
Credit agreement member.
Common stock, shares issued
Common Stock, Shares, Issued
Common stock issued
Segment Reporting [Line Items]
Segment Reporting Information [Line Items]
Broadridge Corporate Issuer Solutions
Broadridge Corporate Issuer Solutions [Member]
Broadridge Corporate Issuer Solutions.
Weighted-Average Remaining Term, Exercised
Class Of Warrant Or Right Exercised Weighted Average Remaining Contractual Term
Class of warrant or right exercised weighted average remaining contractual term.
Counterparty Name
Counterparty Name [Domain]
Two Thousand Twenty Five Common Warrants [Member]
Two thousand twenty five common warrants.
2025 Common Warrants
Deferred payment from Medexus
Deferred payment
Disposal Group Including Discontinued Operations Deferred Revenue
Disposal group including discontinued operations deferred revenue.
Repayment of debt
Repayments of Debt
Government Assistance [Line Items]
Related Party Transaction [Line Items]
Unvested RSUs
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units
Weighted-Average Remaining Term, Exercisable
Class Of Warrant Or Right Exercisable Weighted Average Remaining Contractual Term
Class of warrant or right exercisable weighted average remaining contractual term.
Number of Shares, Issued
Class Of Warrant Or Right Issued
Class of warrant or right issued.
Reverse stock split.
Reverse Stock Split [Abstract]
Number of common stock to be issued up conversion of warrants
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Warrants to purchase common stock
Share based compensation arrangement by share based payment award equity instruments other than options, expected to vest, weighted average grant date fair value.
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Weighted Average Grant Date Fair Value
Weighted Average Fair Value per Unit, Expected to Vest
Weighted average fair value
Government Assistance, Type [Domain]
Maximum borrowing capacity
Line of Credit Facility, Maximum Borrowing Capacity
Subsequent Event Type [Domain]
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]
Percentage of cost related to research and development
Research And Development Cost Percentage
Research and development cost percentage.
Current restricted cash
Restricted cash
Restricted Cash, Current
Dividend attributable to down round feature of warrants
Warrant, Down Round Feature, Decrease in Net Income to Common Shareholder, Amount
Increase in net loss attributable to common equity due to deemed dividend
Dividend attributable to down round feature of warrants
Assumptions Used in Estimating Fair Value of Common Warrants under Black-Scholes Valuation Model
Assumptions Of Fair Value Of Warrants [Table Text Block]
Assumptions of fair value of warrants.
Debt Instrument [Table]
Schedule of Long-Term Debt Instruments [Table]
General and Administrative Expense, Total
General and administrative
General and Administrative Expense
Income Statement [Abstract]
Percentage of Gross Sales Price Shares Sold
Percentage of gross sales price shares sold.
Percentage of gross sales price shares sold
Transaction costs for milestones related to sale of royalties
Transaction costs
Transaction Costs For Milestones Related To Sale Of Royalties
Transaction costs for milestones related to sale of royalties.
Weighted-Average Remaining Term, Expired
Class of warrant or right expired weighted average remaining contractual term
Class of warrant or right expired weighted average remaining contractual term.
Stock Purchase Agreement [Member]
Stock Purchase Agreement [Member]
Equity
Shareholders' Equity and Share-Based Payments [Text Block]
Cash equivalents, maturity period
Cash Equivalents Maturity Period
Cash equivalents maturity period.
Preferred share purchase right
Dividend Declared Of Preferred Share Purchase Right
Dividend declared of preferred share purchase right.
Components of Lease Expense
Lease, Cost [Table Text Block]
Additional amount to be received upon exercise of warrants
Additional Amount To Be Received Upon Exercise Of Warrants
Additional amount to be received upon exercise of warrants.
Government Grant Reimbursements
Governmentgrantreimbursements.
Basic net loss per share
Basic net loss per share
Earnings Per Share, Basic
Document Period End Date
Document Period End Date
Stock plan termination period
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Common stock, shares authorized
Common Stock, Shares Authorized
Statement of Stockholders' Equity [Abstract]
Warrants and Rights Outstanding, Measurement Input
Warrants measurement input
Prepaid Expense and Other Assets, Current
Prepaid expenses and other current assets
Total prepaid expenses and other current assets
Accounting standard update 2017 05.
Accounting Standard Update 2017 05 [Member]
ASC 610-20
Percentage of entitlement to receive Canadian approval milestone payment
Percentage of entitlement to receive Canadian Approval Milestone Payment
Percentage of entitlement to receive Canadian approval milestone payment.
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Common Class B [Member]
Series B
Total assets
Assets
Title of 12(b) Security
Title of 12(b) Security
Proceeds from Equity Method Investment, Distribution, Return of Capital
Proceeds from a strategic equity investment
Reverse stock split.
Reverse Stock Split [Table]
Preferred stock: $0.001 par value; 15,000,000 shares authorized, zero shares issued or outstanding
Preferred Stock, Value, Issued
Related Party Transaction
Related Party Transaction [Axis]
Reclassification, Comparability Adjustment [Policy Text Block]
Reclassification
Summary of Stock-based Compensation Expense Includes Amortization of Stock Options and Restricted Stock Units Granted
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Title of Individual
Title and Position [Domain]
For operating leases
Operating Lease, Payments
Summary of RSU Activity
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
Schedule Of Earnings Per Share Basic And Diluted [Table]
Schedule Of Earnings Per Share Basic And Diluted [Table]
Schedule of earnings per share basic and diluted.
Stockholders' Equity Note, Stock Split, Conversion Ratio
Reverse stock split
Variable Rate [Axis]
Variable Rate
Measurement Input, Option Volatility [Member]
Expected Volatility
RUXIENCE royalties paid by Pfizer to HCR
One time payment of royalties
Payments for Royalties
Lincoln Park
Lincoln Park [Member]
Lincoln Park Member
Increase (Decrease) in Operating Lease Liability
Operating lease liability
Cash
Cash
Leases
Lessee, Operating Leases [Text Block]
Balance
Balance
Equity, Attributable to Parent
Total stockholders' equity
Entity Address, Address Line Two
Entity Address, Address Line Two
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Earnings Per Share [Text Block]
Net Loss per Share
Registered Direct Offering
Registered Direct Offering [Member]
Registered Direct Offering.
Warrant Inducement Agreement [Member]
Warrant Inducement Agreement
Warrant inducement agreement.
Class of Warrant or Right, Date from which Warrants or Rights Exercisable
Warrants exercisable date
Beneficial ownership limitation
Beneficial ownership limitation.
Liability related to sale of royalties, beginning balance
Liability related to sale of royalties, ending balance
Liability Related To Sale Of Royalties
Liability related to sale of royalties.
Debt outstanding
Long-Term Debt
Long-Term Debt, Total
Credit Facility
Credit Facility [Axis]
Kamada [Member]
Kamada.
Andy Hill Cancer Research Endowment (CARE) Fund [Member]
Andyhillcancerresearchendowment(CARE)fundmember
Accrued clinical, research and development costs
Accrued clinical, research and development costs.
Accrued clinical, research and development costs
Adjustments to Additional Paid in Capital, Stock Split
Payment in lieu of fractional shares in connection with the 1-for-44 reverse stock split effected on March 5, 2024
Payment in lieu of fractional shares
Warrants expiration date
Warrants and Rights Outstanding, Maturity Date
Weighted-Average Exercise Price, Issued
Class Of Warrant Or Right Issued Weighted Average Exercise Price
Class of warrant or right issued weighted average exercise price.
Payment of royalty purchase agreement
Payment Of Royalty Purchase Agreement Percentage
Payment of Royalty Purchase Agreement, Percentage.
Exercise Price of 17,982.00 [Member]
Exercise price of 17,982.00.
Exercise Price of 17,982.00
Statistical Measurement
Statistical Measurement [Axis]
Entity Interactive Data Current
Entity Interactive Data Current
First and Second SEPA
First and Second SEPA [Member]
First and Second SEPA.
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common Stock, Value, Issued
Common stock value
Common stock: $0.001 par value; 500,000,000 shares authorized; 1,418,952 and 997,830 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Computation of Basic and Diluted Net Loss per Share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Non Rule 10b51 Arr Modified [Flag]
Non Rule 10b51 Arr Modified [Flag]
Non-Rule 10b5-1 Arrangement Modified
Total liabilities
Liabilities
Summary of Reconciliation of Carrying Amounts of Assets and Liabilities and Income (Loss) from Discontinued Operation
Disposal Groups, Including Discontinued Operations [Table Text Block]
Retained Earnings (Accumulated Deficit), Total
Accumulated deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Percentage of entitlement to receive deferred payments
Percentage of entitlement to receive deferred payments
Percentage of entitlement to receive deferred payments.
Level Three
Fair Value, Inputs, Level 3 [Member]
Other income:
Other Nonoperating Income (Expense) [Abstract]
Percentage of Commitment Fee
Percentage of commitment fee.
Percentage of commitment fee
Accounts payable
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Accounts Payable, Total
Share Price
Share price
Weighted-Average Remaining Term, Issued
Class Of Warrant Or Right Issued Weighted Average Remaining Contractual Term
Class of warrant or right issued weighted average remaining contractual term.
Fair Value Measurement Inputs and Valuation Techniques [Table]
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Issuances of pre-funded warrants, shares
Proceeds from issuances of pre-funded warrants, shares.
Proceeds From Issuances Of Pre-funded Warrants, Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Stock plan vesting period
Common stock price per share
Shares Issued, Price Per Share
Offering price
Issuance of common stock shares
Issuance of common stock ,shares
Issuance of common stock, shares
Private placement share agreed to sell
Maximum number of returning shares from old plan to be add to shares reserve
Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Returning Shares From Old Plan To Be Added To Shares Reserve
Share based compensation arrangement by share based payment award maximum number of returning shares from old plan to be added to shares reserve.
Fair Value Measurement Inputs and Valuation Techniques [Abstract]
Weighted-Average Exercise Price, Exercisable
Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
Class of warrant or right exercisable weighted average exercise price.
Number of Shares, Outstanding, Ending Balance
Number of Shares, Outstanding, Beginning Balance
Warrants outstanding
Class of Warrant or Right, Outstanding
Outstanding warrants issued
Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities [Abstract]
Prepaid expenses, other current assets, accrued expenses, and other current liabilities.
Public Offering
IPO [Member]
Variable Rate
Variable Rate [Domain]
Related Party Transactions [Abstract]
Operating lease cost
Operating Lease, Cost
Dividend Attributable To Down Round Feature Of Warrants
Dividend Attributable To Down Round Feature Of Warrants
Dividend attributable to down round feature of warrants
Long-Lived Tangible Asset
Long-Lived Asset, Class [Axis]
Warrant modification - incremental value
Warrant modification incremental value.
Warrant modification incremental value
Subsequent Events [Text Block]
Subsequent Events
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Axis]
Government Assistance, Award Amount
Reverse stock split.
Reverse Stock Split [Line Item]
Gain on contingent consideration
Discontinued Operating Gain On Contingent Consideration
Discontinued Operating Gain on Contingent Consideration.
Operating Lease, Liability, Current
Operating lease liability, current portion
Current portion of operating lease liabilities
IXINITY.
IXINITY
I X I N I T Y [Member]
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Net loss
Operating lease option to extend
Lessee, Operating Lease, Existence of Option to Extend [true false]
Liabilities and Equity
Total liabilities and stockholders' equity
Research and Development Expense, Total
Research and development
Research and Development Expense
Proceeds of warrants issued during period net
Proceeds Of Warrants Issued During Period Net
Proceeds of warrants issued during period net.
Series A and Series B Common Warrants
Series A and Series B common warrants [Member]
Series A and Series B common warrants.
Lessee Lease Description [Table]
Lessee, Lease, Description [Table]
Document Fiscal Period Focus
Document Fiscal Period Focus
Office Space Lease
Office Space Lease [Member]
Office space lease.
Series a two common warrants.
Series A Two Common Warrants [Member]
Series A-2 Common Warrants
Assumptions used in Valuing the Stock Options Granted under Black-Scholes Valuation Model
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Beneficial Ownership Limitation Percentage
Beneficial ownership limitation percentage.
Beneficial ownership limitation percentage
Common Stock Shares Issuance Approval Threshold Percentage
Common stock shares issuance approval threshold percentage.
Percentage of outstanding shares approved for potential issuance
Title of Individual
Title and Position [Axis]
Two Thousand Twenty Four Common Warrants [Member]
2024 Common Warrants.
2024 Common Warrants
Line of credit facility, used borrowing capacity
Line of Credit Facility, Current Borrowing Capacity
Sale of Stock [Axis]
PIPE Warrants.
PIPE Warrants
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Increase (decrease) in cash and cash equivalents
Entity Current Reporting Status
Entity Current Reporting Status
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Class of Stock
Class of Stock [Domain]
Grant Agreement
Government Assistance [Text Block]
Accounts Payable, Current
Accounts Payable, Current, Total
Accounts payable
Aptevo BioTherapeutics
Aptevo BioTherapeutics [Member]
Aptevo BioTherapeutics.
Summary of Potentially Dilutive Shares Excluded from Calculation of Net Loss Per Share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Assets, Fair Value Disclosure
Assets, Fair Value Disclosure, Total
Fair value assets
First Standby Equity Purchase Agreement [Member]
First standby equity purchase agreement member.
First Standby Equity Purchase Agreement
Document Transition Report
Document Transition Report
Liability Class
Liability Class [Axis]
Subsequent Event [Line Items]
Class of Warrant or Right [Axis]
Accounting Standards Update [Domain]
Closing payments
Closing payments received
Closing payments received.
Current liabilities:
Liabilities, Current [Abstract]
Unrecognized compensation expense
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Securities Purchase Agreement.
Securities Purchase Agreement
Disposal Group Name
Disposal Group Name [Axis]
Common Stock
Common Stock [Member]
Accounting Standards Update [Axis]
Beneficial ownership exceeding percentage of outstanding common stock
Beneficial ownership exceeding percentage of outstanding common stock.
Beneficial ownership exceeding percentage of outstanding common stock
Credit Facility
Credit Facility [Domain]
Statistical Measurement
Statistical Measurement [Domain]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Second Standby Equity Purchase Agreement [Member]
Second Standby Equity Purchase Agreement member.
Second Standby Equity Purchase Agreement
Prepaid Expense, Current
Prepaid Expense, Current, Total
Prepaid clinical expenses
Equity, Attributable to Parent [Abstract]
Stockholders' equity:
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted Average Number of Shares Outstanding, Basic
Basic shares used in calculation
ASSETS
Assets [Abstract]
Entity Central Index Key
Entity Central Index Key
Proceeds of warrants issued during period gross.
Proceeds Of Warrants Issued During Period Gross
Gross proceeds from the offering
Gross proceeds
Antidilutive Securities
Antidilutive Securities [Axis]
Line Of Credit Facility [Table]
Line of Credit Facility [Table]
Current Fiscal Year End Date
Current Fiscal Year End Date
Equity Distribution Agreement
Equity Distribution Agreement [Member]
Equity distribution agreement.
Class of Warrant or Right [Domain]
Document Quarterly Report
Document Quarterly Report
Class of warrant or right, expired.
Number of Shares, Expired
Class of warrant or right, expired
Payment Interest Purchase Agreement
Payment Interest Purchase Agreement [Member]
Payment interest purchase agreement.
Proceeds from milestones related to sale of royalties
Proceeds From Milestones Related To Sale Of Royalties
Proceeds from milestones related to sale of royalties.
Summary of Right of Use Assets Acquired Under Operating Leases
Summary Of Right Of Use Assets Acquired Under Operating Leases Table [Text Block]
Summary of right of use assets acquired under operating leases.
Disposal Group Name
Disposal Group Name [Domain]
Level Two
Fair Value, Inputs, Level 2 [Member]
Warrant Inducement and Reload Letters.
Warrant Inducement and Reload Letters
Net cash used in operating activities
Net cash used in operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash used in operating activities
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Payment of royalty revenue
Payment of royalty revenue, percentage
Payment Of Royalty Revenue Percentage
Payment of royalty revenue, percentage.
Diluted net loss per share
Diluted net loss per share
Earnings Per Share, Diluted
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period
Number of shares issued under share-based payment arrangement
Number of shares sold
Sale of Stock, Number of Shares Issued in Transaction
Dividends
Dividends, Total
Deemed dividend
Preferred stock, par value
Preferred Stock, Par or Stated Value Per Share
Weighted discount rate for operating leases
Operating Lease, Weighted Average Discount Rate, Percent
Accounts receivable and deferred payments from Medexus
Disposal Group Including Discontinued Operations Accounts Receivable And Deferred Revenue
Disposal group including discontinued operations accounts receivable and deferred revenue.
Net loss
Net loss
Long-Lived Tangible Asset
Long-Lived Asset, Class [Domain]
Series A common warrant.
Series A Common Warrant [Member]
Series A Common Warrants
Two Thousand Twenty Three Common Warrants [Member]
2023 Common Warrants.
2023 Common Warrants
Rule 10b51 Arr Modified [Flag]
Rule 10b51 arr modified flag.
Rule 10b5-1 Arrangement Modified
Exercise Price of 3,096.00
Exercise Price of 3,096.00 [Member]
Exercise price of 3,096.00.
Research and development expense
Reduction In Research And Development Expense
Reduction in research and development expense.
Weighted-Average Exercise Price, Outstanding, Ending Balance
Weighted-Average Exercise Price, Outstanding, Beginning Balance
Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
Class of warrant or right outstanding weighted average exercise price.
Nature of Business and Significant Accounting Policies
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]
Right to purcahse additional shares
Right to Purchase Additional Shares
Right to purchase additional shares.
Scenario
Scenario [Domain]
Payment of commitment fees
Payment of Commitment Fee
Payment of commitment fee.
Equity Components
Equity Components [Axis]
Investing Activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Collaboration Agreements
Collaborative Arrangement Disclosure [Text Block]
Statement of Cash Flows [Abstract]
Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities [Text Block]
The entire disclosure for prepaid expenses, other current assets, accrued expenses, and other current liabilities.
Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Domain]
Stockholders' Equity, Reverse Stock Split
Reverse Stock Split, outstanding common stock
Cash and Cash Equivalents Disclosure [Text Block]
Cash and Cash Equivalents
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expense and Other Assets
Series A Junior Participating Preferred Stock [Member]
Series A Junior Participating Preferred Stock [Member]
Series A Junior Participating Preferred Stock.
Fair Value Measurements
Fair Value Disclosures [Text Block]
Stock Offering Aggregate Price
Stock offering aggregate price.
Stock offering aggregate price
Depreciation, Depletion and Amortization, Total
Depreciation and amortization
Depreciation, Depletion and Amortization
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Investor Rights Agreement [Member]
Investor rights agreement.
Class of Stock
Class of Stock [Axis]
Anti-dilutive shares excluded from calculation of diluted net loss per share
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Counterparty Name
Counterparty Name [Axis]
Measurement Input, Expected Term [Member]
Expected Average Life of Warrants
Number of operating segments
Number of Operating Segments
Number of shares available for grant
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
September 2024 Registered Direct Offering [Member]
September 2024 Registered Direct Offering [Member]
September 2024 Registered Direct Offering
Basic and Diluted Net Income (Loss) per Share [Abstract]
Basic and diluted net income (loss) per share.
Basic and diluted net loss per share:
Sale Of Royalties Liability Disclosure [Abstract]
Sale of royalties liability disclosure abstract.
Summary Of Significant Asset Categories [Table Text Block]
Summary of significant asset categories.
Summary of Significant Asset Categories
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Accrued expenses and other current liabilities
Accrued expenses and other current liabilities
Proceeds from sale of investments
Proceeds From Sale Of Investments
Proceeds from Sale of Investments.
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares, Outstanding, Beginning balance
Number of Shares, Outstanding, Ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Number of shares outstanding under share-based payment arrangement
Document Type
Document Type
Non-employee Directors
Non Employee Directors [Member]
Non-employee directors.
Operating Activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operations [Line Items]
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Liabilities and Equity [Abstract]
LIABILITIES AND STOCKHOLDERS' EQUITY
Lessee Lease Description [Line Items]
Lessee, Lease, Description [Line Items]
Outstanding Options to Purchase Common Stock
Subsequent Event [Member]
Subsequent Events
Loss from operations
Operating Income (Loss)
Measurement Input, Risk Free Interest Rate [Member]
Risk-free Interest Rate
Sale of stock per share
Sale of Stock, Price Per Share
Average price
2018 Stock Incentive Plan
Two Thousand Eighteen Stock Incentive Plan [Member]
Two thousand eighteen stock incentive plan.
Disposal Group Classification [Axis]
Entity File Number
Securities Act File Number
April Two Thousand Twenty Four Warrants [Member]
April two thousand twenty four warrants.
April 2024 Warrant
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures, Total
Common stock issued upon vesting of restricted stock units
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures
Measurement Input, Exercise Price [Member]
Exercise Price
Accrued Liabilities and Other Liabilities
Accrued expenses and other current liabilities
Total accrued expenses and other current liabilities
Liability Related to Sale of Royalties
Liability Related To Sale Of Royalties Disclosure [Text Block]
Liability related to sale of royalties disclosure.
HCR [member].
H C R [Member]
HCR
Milestone payment
Milestone Payment
Milestone payments.
Accumulated Deficit
Retained Earnings [Member]
Entity Registrant Name
Entity Registrant Name
Shares issued
Shares, Issued
Accounting Policies [Abstract]
Warrant Issue During Period
Warrant Issue During Period.
Warrant issued during period
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Proceeds from royalties received
Proceeds from Royalties Received
Operating lease renewal option term
Lessee, Operating Lease, Renewal Term
Niowave Additional Share Purchase Right [Member]
Niowave Additional Share Purchase Right
Niowave additional share purchase right.
Significant Accounting Policies [Policy Text Block]
Significant accounting policies.
Significant Accounting Policies
Issuance costs
Common Stock Issuance Costs
Common stock issuance costs.
Entity Address, Address Line One
Entity Address, Address Line One
Discontinued Operations
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]
Ownership Percentage
Ownership percentage.
Ownership percentage
Options expected to vest, weighted average period
Sharebased Compensation Arrangement By Sharebased Payment Award Options Expected To Vest Weighted Average Period
Sharebased compensation arrangement by sharebased payment award options expected to vest weighted average period.
Liability related to sale of royalties, non-current
Liability Related To Sale Of Royalties Non Current
Liability related to sale of royalties non current.
Net proceeds from sale of stock
Proceeds from Issuance or Sale of Equity
Proceeds from Issuance or Sale of Equity, Total
Total current assets
Assets, Current
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value, Recurring and Nonrecurring [Table]
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information
Purchase Agreement
Purchase Agreement [Member]
Purchase agreement.
XOMA Transaction
Related Party Transactions Disclosure [Text Block]
Number of Units, Outstanding and expected to vest
Share Based Compensation Arrangement By Share Based Payment Award Equity Instrument Other Than Options Nonvested And Expected To Vest Number
Share based compensation arrangement by share based payment award equity instrument other than options nonvested and expected to vest number.
Reverse stock split.
Reverse Stock Split
Entity Small Business
Entity Small Business
Series b one common warrants.
Series B One Common Warrants [Member]
Series B-1 Common Warrants
Government Assistance [Abstract]
Unrecognized compensation expense
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Weighted-Average Remaining Term, Outstanding
Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term
Class of warrant or right outstanding weighted average remaining contractual term.
Employee-related Liabilities, Current
Employee-related Liabilities, Current, Total
Accrued compensation and benefits
Non-cash interest expense
Non Cash Interest Expense
Non cash interest expense.
Nasdaq Capital Market
NASDAQ CAPITAL MARKET [Member]
Earnings Per Share [Abstract]
Basic and diluted net loss per share:
Summary of Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Initial operating lease term date
Initial Operating Lease Term Date
Initial operating lease term date.
April 4 2025 Registered Direct Offering [Member]
April 4 2025 registered direct offering.
April 4, 2025 Registered Direct Offering
Plan Name
Plan Name [Axis]
Subsequent Event Type [Axis]
Equity [Abstract]
Proceeds from issuances of pre-funded warrants.
Proceeds From Issuances Of Pre funded Warrants
Issuances of pre-funded warrants
Financing Activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Fair Value by Liability Class
Fair Value by Liability Class [Domain]
Two Thousand Twenty Six Niowave Common Warrants [Member]
Two thousand twenty six niowave common warrants.
2026 Niowave Common Warrants
Proceeds from milestone payments, net of transaction costs
Milestone Payment Received Net Of Transaction Costs
Milestone payment received net of transaction costs.
Payments in lieu of fractional shares.
Payments In Lieu Of Fractional Shares
Payments in lieu of fractional shares
Common Warrant Issued
Common warrant issued.
Common warrant issued
Additional post-closing payment
Additional post-closing payment
Additional post-closing payment.
Number of Shares, Exercisable
Class Of Warrant Or Right Exercisable
Class of warrant or right exercisable
Accounting Pronouncements Pending Adoption
Accounting Pronouncements Pending Adoption [Policy Text Block]
Accounting pronouncements pending adoption.
Entity Tax Identification Number
Entity Tax Identification Number
At The Market Offering [Member]
At The Market Offering.
At-The-Market Offering
At The Market Offering
Equity Component
Equity Component [Domain]
Entity Address, City or Town
Entity Address, City or Town
Other Segment Items
Other segment items.
Other segment items
Hyperimmune Business
Hyperimmune Business [Member]
Hyperimmune business.
Measurement Input Type [Domain]
proceeds from issuance of common stock
Issuance of common stock
Issuance of common stock
Series b two common warrants.
Series B Two Common Warrants [Member]
Series B-2 Common Warrants
New Warrants
New Warrants [Member]
New warrants.
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Additional milestone payment
Additional Milestone Payment
Additional milestone payment.
Exercise Price of $8.60
Exercise Price Of 8.60 [Member]
Exercise price of 8.60.
Number of operating lease renewal option
Number Of Operating Lease Renewal Options
Number of operating lease renewal options.
Shares used in calculation:
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Operating lease renewal option description
Lessee, Operating Lease, Option to Extend
Statement [Table]
Statement [Table]
Total lease cost
Lease, Cost
Stock-based compensation expense
Share-Based Payment Arrangement, Expense
Private Placement and Warrant Inducement
Private Placement And Warrant Inducement [Member]
Private placement and warrant inducement.
Aggregate Beneficial Ownership Limitation Percentage
Aggregate beneficial ownership limitation percentage.
Aggregate beneficial ownership limitation percentage
Entity Shell Company
Entity Shell Company
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash from investing activities
Inducement Warrants.
Inducement Warrants
Weighted-Average Exercise Price, Exercised
Class Of Warrant Or Right Exercised Weighted Average Exercise Price
Class of warrant or right exercised weighted average exercise price.
Statement [Line Items]
Statement [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Maximum
Maximum [Member]
Debt Disclosure [Abstract]
Sale of Stock [Domain]
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Schedule of earnings per share basic and diluted.
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table]
Disposal Groups, Including Discontinued Operations [Table]
Transaction costs
Debt Issuance Costs, Gross
Share portion entitled to purchase by rights
Share Portion Entitled To Purchase By Rights1
Share portion entitled to purchase by rights.
Subsequent Events [Abstract]
Nature Of Business [Line Items]
Nature Of Business [Line Items]
Nature Of Business [Line Items]
Current assets:
Assets, Current [Abstract]
Accrued Professional Fees, Current
Accrued professional service costs
Sale of Stock, Consideration Received on Transaction
Gross proceeds
Net/gross proceeds
Related Party Transaction
Related Party Transaction [Domain]
Leases [Abstract]
Document Fiscal Year Focus
Document Fiscal Year Focus
November Two Thousand Twenty Three Warrants [Member]
November two thousand twenty three warrants.
November 2023 Warrants
Common stock outstanding
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding, Beginning Balance
Common stock, shares outstanding
Common Stock, Shares, Outstanding
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Schedule Of Restricted Cash And Cash Equivalents [Table]
Restrictions on Cash and Cash Equivalents [Table]
Gain on extinguishment of liability related to sale of royalties
Gain from extinguishment of liability related to sale of royalties
Gain On Extinguishment Of Liability Related To Sale Of Royalties
Gain on extinguishment of liability related to sale of royalties.
Government Assistance, Type [Axis]
Schedule of changes in the liability related to the sale of royalties.
Schedule of Changes in the Liability Related to the Sale of Royalties
Schedule Of Changes In Liability Related To Sale Of Royalties Table [Text Block]
April 2024 Common Warrants [Member]
April 2024 common warrants.
April 2024 Warrants
Forecast
Forecast [Member]
Warrant Activity [Table Text Block]
Warrant activity.
Summary of Common Warrant Activity
Two Thousand Twenty Three and Two Thousand Twenty Four Common Warrants [Member]
Two thousand twenty three and two thousand twenty four common warrants.
2023 and 2024 Common Warrants
Series B Common Warrants 2023
Series B Common Warrants [Member]
Series B Common Warrants.
Series B Common Warrants
Long term portion of operating lease liabilities
Operating Lease, Liability, Noncurrent
Operating lease liability, current portion
Modified warrants member.
Modified Warrants [Member]
Modified Warrants
Gain Related to Sale of Nonfinancial Asset
Gain Related to Sale of Nonfinancial Asset [Policy Text Block]
Gain related to sale of nonfinancial asset.
Number of technology platforms
Number Of Technology Platforms
Number of technology platforms.
Niowave [Member]
Niowave.
Other Accrued Liabilities, Current
Other accruals
Additional paid-in capital
Additional Paid in Capital, Common Stock
Security Exchange Name
Security Exchange Name
Measurement Input Type [Axis]
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Adopted Accounting Pronouncements
Recently Adopted Accounting Pronouncements
Warrants
Warrant [Member]
Common Warrants
RUXIENCE
R U X I E N C E [Member]
RUXIENCE
Government Assistance [Table]
Warrants exercise price, per share
Class of Warrant or Right, Exercise Price of Warrants or Rights
Share of common stock underlying common warrants
Entity Address, State or Province
Entity Address, State or Province
Percentage of entitlement to receive European approval milestone payment
Percentage of entitlement to receive European approval milestone payment
Percentage of entitlement to receive European approval milestone payment.
Percentage of beneficial ownership
Percentage Of Beneficial Ownership
Percentage Of Beneficial Ownership.
Number of Shares, Exercised
Class Of Warrant Or Right Exercised
Class of warrant or right exercised.
Common warrants exercised
Stock authorized for issuance under Stock Plan
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Stock authorized for issuance under the plan
Operating lease right-of-use asset
Operating Lease, Right-of-Use Asset
Amendment Flag
Amendment Flag
Debt Instrument
Debt Instrument [Axis]
Other Nonoperating Income (Expense), Total
Other Nonoperating Income (Expense)
Other income, net
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Structuring Fee
Structuring fee.
Structuring fee
Seattle Office Lease, Including Amendment
Seattle Office Lease Including Amendment [Member]
Seattle office lease including amendment.
City Area Code
City Area Code
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Gross proceeds
Costs from issuance of common stock
Proceeds from issuance of common stock and pre-funded warrants exercise, net of issuance costs
Proceeds from issuance of common stock
Operating expenses:
Operating Expenses [Abstract]
December 2024 Warrants
December 2024 Warrants [Member]
December 2024 Warrants.
Weighted-Average Exercise Price, Expired
Class of warrant or right expired weighted average exercise price
Class of warrant or right expired weighted average exercise price.
Common stock, par value
Common Stock, Par or Stated Value Per Share
Par value
Exit fees
Business Exit Costs
Cash and Cash Equivalents [Abstract]
Costs Under the Grant Award Agreement
Costsunderthegrantawardagreement.
Total current liabilities
Liabilities, Current
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Variable expense
Variable Lease, Cost
Segment Information
Segment Reporting [Text Block]
Stock Issued During Period, Shares, Reverse Stock Splits
Payment in lieu of fractional shares in connection with the 1-for-44 reverse stock split effected on March 5, 2024 (in shares)
Payment in lieu of fractional shares, shares
Payment in lieu of fractional shares, shares
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Trading Symbol
Trading Symbol
Warrants issuance costs.
Warrants Issuance Costs
Total issuance costs
Restricted Cash And Cash Equivalents Items [Line Items]
Restricted Cash and Cash Equivalent Item [Line Items]
Subsequent Event [Table]
Nature Of Business [Table]
Nature Of Business [Table]
Nature Of Business [Table]
Entity Emerging Growth Company
Entity Emerging Growth Company
Additional Paid-In Capital
Additional Paid-in Capital [Member]
Summary of Prepaid Expenses and Other Current Assets
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
Money market funds
Cash Equivalent, Money Market Fund, Carrying Value
Plan Name
Plan Name [Domain]
Disposal Group Classification [Domain]
Pre-funded Warrants
Pre-funded Warrants 2023
Pre-funded Warrants [Member]
Pre-funded Warrants.
August Two Thousand Twenty Three Warrants [Member]
August wo thousand twenty three warrants.
August 2023 Warrant
Common Class A [Member]
Series A
Series a one common warrants.
Series A One Common Warrants [Member]
Series A-1 Common Warrants
Cover [Abstract]
Schedule of Cash and Cash Equivalents [Table Text Block]
Schedule of Cash and Cash Equivalents
Summary of Significant Expense Categories
Summary Of Significant Expense Categories [Table Text Block]
Summary of significant expense categories.
Current portion of liability related to sale of royalties
Liability Related To Sale Of Royalties Current
Liability related to sale of royalties current.
Weighted average remaining lease term for operating leases
Operating Lease, Weighted Average Remaining Lease Term
Share-Based Payment Arrangement, Noncash Expense, Total
Stock-based compensation
Share-Based Payment Arrangement, Noncash Expense
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Fair Value Disclosures [Abstract]
Cash and cash equivalents
Cash and Cash Equivalent
Total cash and cash equivalents
Share Repurchase Program, Remaining Authorized, Amount
Remaining availability under SEPA
Remaining availability
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash provided by financing activities
Discontinued Operations and Disposal Groups [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic
Net loss attributable to common stockholders
Net loss attributable to common stockholders
Cash Equivalents, at Carrying Value, Total
Cash equivalents
Cash Equivalents, at Carrying Value
Entity Filer Category
Entity Filer Category
Debt Instrument, Name
Debt Instrument, Name [Domain]
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Warrant modification - incremental fair value
Adjustments to Additional Paid in Capital, Warrant Issued
Warrant modification - incremental value
Property, Plant and Equipment, Net, Total
Property and equipment, net
Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
Balance (in shares)
Balance (in shares)
Shares, Outstanding
Standby Equity Purchase Agreement [Member]
Standby equity purchase agreement.
Standby Equity Purchase Agreement
Segment Reporting [Abstract]
Liability
Liability [Member]
Other current assets
Other Assets, Current
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Statement of Financial Position [Abstract]
Local Phone Number
Local Phone Number